Current Rheumatology Reports

, Volume 4, Issue 4, pp 313–321

Peripheral and central sensitization in musculoskeletal pain disorders: An experimental approach

  • Thomas Graven-Nielsen
  • Lars Arendt-Nielsen
Article

Abstract

This report provides a brief introduction to the manifestations of peripheral and central sensitization involved in musculoskeletal pain disorders. It has become increasingly evident that muscle hyperalgesia, referred pain, referred hyperalgesia, and widespread hyperalgesia play an important role in chronic musculoskeletal pain. A better understanding of the involved basic mechanisms and better methods to assess muscle pain in the clinic may provide new possibilities for designing rational therapies and for targeting the pharmacologic intervention optimally. Peripheral sensitization plays an important role for increased sensitivity of deep tissue. However, central sensitization may be equally important but less addressed. Quantitative sensory testing provides the possibility to evaluate these manifestations in a standardized way in patients with musculoskeletal pain or in healthy volunteers (eg, experimentally induced referred pain can be used to assess the potential involvement of central sensitization in musculoskeletal pain conditions). Central sensitization may play a role in the persistence, amplification, and spread of pain. Interventions should take this aspect into consideration.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Curatolo M, Bogduk N: Pharmacologic pain treatment of musculoskeletal disorders: current perspectives and future prospects. Clin J Pain 2001, 17:25–32.PubMedCrossRefGoogle Scholar
  2. 2.
    Kellgren JH: Observations on referred pain arising from muscle. Clin Sci 1938, 3:175–190.Google Scholar
  3. 3.
    Mense S, Simons DG: Muscle Pain. Understanding Its Nature, Diagnosis, and Treatment. Philadelphia: Lippincott Williams & Wilkins; 2001.Google Scholar
  4. 4.
    Bradley LA, McKendree-Smith NL, Alberts KR, et al.: Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia. Curr Rheumatol Rep 2000, 2:141–148.PubMedGoogle Scholar
  5. 5.
    Arendt-Nielsen L: Induction and assessment of experimental pain from human skin, muscle, and viscera. In Proceedings of the 8th World Congress on Pain. Edited by Jensen TS, Turner JA, Wiesenfeld-Hallin Z. Seattle: IASP Press; 1997:393–425.Google Scholar
  6. 6.
    Svensson P, Graven-Nielsen T: Craniofacial muscle pain: review of mechanisms and clinical manifestations. J Orofac Pain 2001, 15:117–145.PubMedGoogle Scholar
  7. 7.
    Graven-Nielsen T, Segerdahl M, Svensson P, Arendt-Nielsen L: Methods for induction and assessment of pain in humans with clinical and pharmacological examples. In Methods in Pain Research. Edited by Kruger L. Boca Raton: CRC Press; 2001:264–304.Google Scholar
  8. 8.
    Fischer AA: Muscle Pain Syndromes and Fibromyalgia. Pressure Algometry for Quantification of Diagnosis and Treatment Outcome. New York: Haworth Medical Press; 1998.Google Scholar
  9. 9.
    Polianskis R, Graven-Nielsen T, Arendt-Nielsen L: Computercontrolled pneumatic pressure algometrya new technique for quantitative sensory testing. Eur J Pain 2001, 5:267–277.PubMedCrossRefGoogle Scholar
  10. 10.
    Graven-Nielsen T, Mense S: The peripheral apparatus of muscle pain: evidence from animal and human studies. Clin J Pain 2001, 17:2–10.PubMedCrossRefGoogle Scholar
  11. 11.
    Witting N, Svensson P, Gottrup H, et al.: Intramuscular and intradermal injection of capsaicin: a comparison of local and referred pain. Pain 2000, 84:407–412.PubMedCrossRefGoogle Scholar
  12. 12.
    Babenko V, Graven-Nielsen T, Svensson P, et al.: Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin. Pain 1999, 82:1–8. The first human study to describe a potential involvement of bradykinin and serotonin in peripheral sensitization of muscle nociceptors. The combination of serotonin and bradykinin produced experimental muscle pain and muscle hyperalgesia to mechanical stimuli.PubMedCrossRefGoogle Scholar
  13. 13.
    Babenko V, Svensson P, Graven-Nielsen T, et al.: Duration and distribution of experimental muscle hyperalgesia in humans following combined infusions of serotonin and bradykinin. Brain Res 2000, 853:275–281.PubMedCrossRefGoogle Scholar
  14. 14.
    Ernberg M, Lundeberg T, Kopp S: Effect of propranolol and granisetron on experimentally induced pain and allodynia/ hyperalgesia by intramuscular injection of serotonin into the human masseter muscle. Pain 2000, 84:339–346.PubMedCrossRefGoogle Scholar
  15. 15.
    Bhave G, Karim F, Carlton SM, Gereau RW: Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci 2001, 4:417–423.PubMedCrossRefGoogle Scholar
  16. 16.
    Cairns BE, Hu JW, Arendt-Nielsen L, et al.: Sex-related differences in human pain and rat afferent discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2001, 86:782–791. Describes the effects of glutamate injections into human and rat masseter muscle. The results show that glutamate evoke afferent activity in rats and muscle pain in humans. The pain induced in humans and afferent responses in rats were higher in females compared with males, indicating that sex-related differences may be important in peripheral neurobiologic mechanisms involved in chronic musculoskeletal pain.PubMedGoogle Scholar
  17. 17.
    Cairns BE, Gambarota G, Svensson P, et al.: Glutamate-induced sensitization of rat masseter muscle fibers. Neuroscience 2002, 109:389–399.PubMedCrossRefGoogle Scholar
  18. 18.
    Svensson P, Arendt-Nielsen L, Nielsen H, Larsen JK: Effect of chronic and experimental jaw muscle pain on pain-pressure thresholds and stimulus-response curves. J Orofac Pain 1995, 9:347–356.PubMedGoogle Scholar
  19. 19.
    Vecchiet L, Galletti R, Giamberardino MA, et al.: Modifications of cutaneous, subcutaneous and muscular sensory and pain thresholds after the induction of an experimental algogenic focus in the skeletal muscle. Clin J Pain 1988, 4:55–59.CrossRefGoogle Scholar
  20. 20.
    Graven-Nielsen T, Fenger-Grøn LS, Svensson P, et al.: Quantification of deep and superficial sensibility in saline-induced muscle paina psychophysical study. Somatosens Mot Res 1998, 15:46–53.PubMedCrossRefGoogle Scholar
  21. 21.
    Svensson P, Graven-Nielsen T, Arendt-Nielsen L: Mechanical hyperesthesia of human facial skin induced by tonic painful stimulation of jaw muscles. Pain 1998, 74:93–100.PubMedCrossRefGoogle Scholar
  22. 22.
    Leffler AS, Kosek E, Hansson P: Injection of hypertonic saline into musculus infraspinatus resulted in referred pain and sensory disturbances in the ipsilateral upper arm. Eur J Pain 2000, 4:73–82.PubMedCrossRefGoogle Scholar
  23. 23.
    Slater H, Arendt-Nielsen L, Wright A, Graven-Nielsen T: Deep tissue pain in wrist extensorsa model of lateral epicondylalgia. J Musculoskelet Pain 2001, 9:95.Google Scholar
  24. 24.
    Barlas P, Walsh DM, Baxter GD, Allen JM: Delayed onset muscle soreness: effect of an ischaemic block upon mechanical allodynia in humans. Pain 2000, 87:221–225.PubMedCrossRefGoogle Scholar
  25. 25.
    Bajaj P, Graven-Nielsen T, Wright A, et al.: Muscle hyperalgesia in postexercise muscle soreness assessed by single and repetitive ultrasound stimuli. J Pain 2000, 1:111–121.CrossRefGoogle Scholar
  26. 26.
    Vecchiet L, Vecchiet J, Giamberardino MA: Referred muscle pain: clinical and pathophysiologic aspects. Curr Rev Pain 1999, 3:489–498.PubMedGoogle Scholar
  27. 27.
    Arendt-Nielsen L, Laursen RJ, Drewes AM: Referred pain as an indicator for neural plasticity. Prog Brain Res 2000, 129:343–356.PubMedCrossRefGoogle Scholar
  28. 28.
    Arendt-Nielsen L, Svensson P: Referred muscle pain: basic and clinical findings. Clin J Pain 2001, 17:11–19.PubMedCrossRefGoogle Scholar
  29. 29.
    Laursen RJ, Graven-Nielsen T, Jensen TS, Arendt-Nielsen L: The effect of compression and regional anaesthetic block on referred pain intensity in humans. Pain 1999, 80:257–263. Determined to which degree referred pain depends on peripheral or central mechanisms by blocking sensory input from the referred pain area. Referred pain was present despite the regional anesthesia, although the referred pain intensity was decreased. Therefore, referred pain is based mainly on a central mechanism and partly depends on peripheral sensory input.PubMedCrossRefGoogle Scholar
  30. 30.
    Hoheisel U, Mense S, Simons DG, Yu X-M: Appearance of new receptive fields in rat dorsal horn neurons following noxious stimulation of skeletal muscle: a model for referral of muscle pain? Neurosci Lett 1993, 153:9–12.PubMedCrossRefGoogle Scholar
  31. 31.
    Simons DG, Travell JG, Simons LS: Myofascial Pain and Dysfunction. The Trigger Point Manual. Baltimore: Lippincott Williams & Wilkins; 1999.Google Scholar
  32. 32.
    Sörensen J, Graven-Nielsen T, Henriksson KG, et al.: Hyperexcitability in fibromyalgia. J Rheumatol 1998, 25:152–155.PubMedGoogle Scholar
  33. 33.
    Staud R, Vierck CJ, Cannon RL, et al.: Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001, 91:165–175.PubMedCrossRefGoogle Scholar
  34. 34.
    Wright A, Graven-Nielsen T, Davies I, Arendt-Nielsen L: Temporal summation of pain from skin, muscle and joint following nociceptive ultrasonic stimulation in humans. Exp Brain Res 2002, 144:475–482.PubMedCrossRefGoogle Scholar
  35. 35.
    Graven-Nielsen T, Kendall SA, Henriksson KG, et al.: Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000, 85:483–491. The exaggerated referred pain areas evoked by hypertonic saline and facilitated temporal summation to intramuscular electrical stimulation previously found in patients with fibromyalgia was pharmacologically decreased by ketamine targeting central sensitization. The facilitated mechanisms for referred pain and temporal summation were reduced by ketamine compared with placebo, which strongly indicates involvement of central sensitization in fibromyalgia.PubMedCrossRefGoogle Scholar
  36. 36.
    Johansen MK, Graven-Nielsen T, Olesen AS, Arendt-Nielsen L: Generalised muscular hyperalgesia in chronic whiplash syndrome. Pain 1999, 83:229–234. Assessed referred pain pattern to intramuscular infusion of hypertonic saline and the muscle sensitivity to pressure in areas within and outside the region involved in the whiplash trauma. Hyperalgesia to pressure and enlarged referred pain areas were found in patients with chronic whiplash syndrome compared with control subjects within and outside the traumatized area, suggesting central sensitization.CrossRefGoogle Scholar
  37. 37.
    Curatolo M, Petersen-Felix S, Arendt-Nielsen L, et al.: Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain 2001, 17:306–315.PubMedCrossRefGoogle Scholar
  38. 38.
    Bajaj P, Graven-Nielsen T, Arendt-Nielsen L: Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study. Pain 2001, 93:107–114. This study shows that persistent joint chronic nociceptive input can facilitate the central processing of muscle nociceptive input in humans. Muscle sensitivity and referred pain pattern were assessed in patients with knee osteoarthritis by intramuscular infusion of hypertonic saline into the tibialis anterior muscle. Increased pain intensity and enlarged pain areas were found in patients versus controls, suggesting involvement of central sensitization.PubMedCrossRefGoogle Scholar
  39. 39.
    Svensson P, List T, Hector G: Analysis of stimulus-evoked pain in patients with myofascial temporomandibular pain disorders. Pain 2001, 92:399–409. This study assessed the somatosensory sensitivity within and outside the craniofacial region in patients with myofascial temporomandibular disorder compared with controls. Sensitivity to pressure and infusion of hypertonic saline into the masseter and tibialis anterior muscle were assessed. The responsiveness to pressure and experimental muscle pain in the craniofacial region was higher in patients compared with a control group. Moreover, the pressure sensitivity was increased in the tibialis anterior muscle, suggesting widespread hyperalgesia.PubMedCrossRefGoogle Scholar
  40. 40.
    Graven-Nielsen T, Arendt-Nielsen L, Svensson P, Jensen TS: Stimulus-response functions in areas with experimentally induced referred muscle paina psychophysical study. Brain Res 1997, 744:121–128.PubMedCrossRefGoogle Scholar
  41. 41.
    Tuveson B, Lindblom B, Fruhstorfer H: Experimental muscle pain and sensory changes at the site of referred pain. 22nd Annual Meeting. Reykjavik, Iceland: SASP; 1999:77.Google Scholar
  42. 42.
    Graven-Nielsen T, Gibson SJ, Laursen, RJ, et al.: Opioid insensitive hypoalgesia to mechanical stimuli at sites ipsilateral and contralateral to experiemental muscle pain in human volunteers. Exp Brain Res 2002; In press.Google Scholar
  43. 43.
    Graven-Nielsen T, Babenko V, Svensson P, Arendt-Nielsen L: Experimentally induced muscle pain induces hypoalgesia in heterotopic deep tissues, but not in homotopic deep tissues. Brain Res 1998, 787:203–210.PubMedCrossRefGoogle Scholar
  44. 44.
    Svensson P, Hashikawa CH, Casey KL: Site- and modalityspecific modulation of experimental muscle pain in humans. Brain Res 1999, 851:32–38.PubMedCrossRefGoogle Scholar
  45. 45.
    Stohler CS, Kowalski CJ, Lund JP: Muscle pain inhibits cutaneous touch perception. Pain 2001, 92:327–333.PubMedCrossRefGoogle Scholar
  46. 46.
    Gjerstad J, Tjolsen A, Svendsen F, Hole K: Inhibition of evoked C-fibre responses in the dorsal horn after contralateral intramuscular injection of capsaicin involves activation of descending pathways. Pain 1999, 80:413–418.PubMedCrossRefGoogle Scholar
  47. 47.
    Gjerstad J, Tjolsen A, Svendsen F, Hole K: Inhibition of spinal nociceptive responses after intramuscular injection of capsaicin involves activation of noradrenergic and opioid systems. Brain Res 2000, 859:132–136.PubMedCrossRefGoogle Scholar
  48. 48.
    Leffler AS: Pain Influences Somatosensory Perception An Experimental and Clinical Study [Doctor of Pharmacy thesis]. Stockholm, Sweden: Karolinska Institute; 2002.Google Scholar
  49. 49.
    Leffler AS, Kosek E, Hansson P: The influence of pain intensity on somatosensory perception in patients suffering from subacute/ chronic lateral epicondylalgia. Eur J Pain 2000, 4:57–71.PubMedCrossRefGoogle Scholar
  50. 50.
    Leffler AS, Kosek E, Lerndal T, et al.: Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. Eur J Pain 2002, 6:161–176. This study describes the influence of ongoing rheumatoid arthritic pain, with two different disease durations, on somatosensory sensitivity and descending inhibitory pain control mechanism. In addition to hyperalgesia to pressure over the painful joint, widespread hyperalgesia to pressure was found in the patient group with the longest disease duration compared with controls. The descending inhibitory control of pain was unaffected in any of the patient groups. The widespread hyperalgesia to pressure detected in the group with long-term pain conditions indicated the development of central sensitization.PubMedCrossRefGoogle Scholar
  51. 51.
    Bajaj P, Graven-Nielsen T, Arendt-Nielsen L: Trigger points in patients with lower limb osteoarthritis. J Musculoskelet Pain 2001, 9:17–33.CrossRefGoogle Scholar
  52. 52.
    Kosek E, Hansson P: Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 1997, 70:41–51.PubMedCrossRefGoogle Scholar
  53. 53.
    Kosek E, Ordeberg G: Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain 2000, 88:69–78. Assessed the influence of chronic nociceptive pain on endogenous pain modulation in patients with painful osteoarthritis. Before painrelieving surgery, heterotopic noxious conditioning stimulation did not decrease the sensitivity to pressure stimulation as seen in painfree control patients. After surgery, the patients responded as controls, indicating an intact descending inhibitory control, although fully activated or maintained by chronic musculoskeletal pain.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2002

Authors and Affiliations

  • Thomas Graven-Nielsen
    • 1
  • Lars Arendt-Nielsen
    • 1
  1. 1.Center for Sensory-Motor Interaction, Laboratory for Experimental Pain ResearchAalborg UniversityAalborg EDenmark

Personalised recommendations